Severe outcomes have been particularly observed in patients with coexisting chronic inflammatory conditions, such as hypertension, diabetes, and obesity, which are in turn linked with elevated plasma GDF-15 levels (76). Here, GDF15 is linked to obesity due to melanocortin 4 receptor deficiency.